Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

INTRODUCTION: Receptor radionuclide therapy is a promising treatment modality for patients with neuroendocrine tumors for whom alternative treatments are limited. The aim of this study was to investigate the incidence of hormonal crises after therapy with the radiolabeled somatostatin analogue [(177...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: de Keizer, Bart, van Aken, Maarten O., Feelders, Richard A., de Herder, Wouter W., Kam, Boen L. R., van Essen, Martijn, Krenning, Eric P., Kwekkeboom, Dik J.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2008
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2668649/
https://ncbi.nlm.nih.gov/pubmed/18210106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-007-0691-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares